Stay updated on Partially Supervised Conditioning in CF Clinical Trial

Sign up to get notified when there's something new on the Partially Supervised Conditioning in CF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Partially Supervised Conditioning in CF Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:44:17.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 on the webpage has recently changed to 8, indicating a shift in the forced expiratory volume in 1 second (FEV1) in cystic fibrosis patients undergoing a partially supervised exercise intervention. This change reflects potential improvements in pulmonary function and overall quality of life for the participants.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:04.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying both inclusion and exclusion criteria for participants, such as a confirmed diagnosis of Cystic Fibrosis and age requirements. Previously, this section only indicated that no information was provided.
    Difference
    15%
    Check dated 2024-05-22T21:23:47.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:56:37.000Z thumbnail image

Stay in the know with updates to Partially Supervised Conditioning in CF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Partially Supervised Conditioning in CF Clinical Trial page.